Our study is the first study in which both the gene and protein product of FMNL1 and PAK1 were detected and compared in circulation and urine, and it is important because it shows that both marker molecules have low expression levels in early-stage PCa. This evidence concerns the gene FMNL1 and posterior cortical atrophy.